Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs

Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs

The COVID-19 pandemic has disrupted life throughout the world. Newly developed vaccines promise relief to people who live in high-income countries, although vaccines and expensive new treatments are unlikely to arrive in time to help people who live in low-and middle-income countries. The pathogenes...

Full description

Bibliographic Details
Main Authors: Geert Byttebier, Luc Belmans, Myriam Alexander, Bo E. H. Saxberg, Bart De Spiegeleer, Anton De Spiegeleer, Nick Devreker, Jens T. Van Praet, Karolien Vanhove, Reinhilde Reybrouck, Evelien Wynendaele, David S. Fedson
Format: Article
Language:English
Published: Taylor & Francis Group 2021-09-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
covid-19
mortality
propensity score
case-control
statins
ace inhibitors
angiotensin receptor blockers
immunometabolism
Online Access:http://dx.doi.org/10.1080/21645515.2021.1920271

Internet

http://dx.doi.org/10.1080/21645515.2021.1920271

Similar Items